Malaysia’s state-owned private equity firm Ekuiti Nasional Bhd (Ekuinas) announced that it has acquired an 80% stake in active pharmaceutical ingredient (API) manufacturer Symbiotica Specialty Ingredients (Symbiotica).
Continue Reading: Unlock Free Insights!
Stay updated with 3 free articles every month
Access our exclusive newsletters delivered to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in